What question did this study set out to answer?

The aim is to investigate how Sfrp2 in microglia influences neuroinflammation and protects the retina after ischemia-reperfusion injury.

March 7, 2026Open Access

Sfrp2 in Microglia Inhibited S100a8-Mediated Neuroinflammation and Protected Neural Damage Following Retinal Ischemia-Reperfusion

Q: What does this research mean for the field?

Sfrp2 in microglia inhibits S100a8-mediated neuroinflammation and protects against neural damage following retinal ischemia-reperfusion. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

Key Points

The aim is to investigate how Sfrp2 in microglia influences neuroinflammation and protects the retina after ischemia-reperfusion injury.
Inhibition of TRAF6-TAK1-NF-κB signaling pathway
Assessment of inflammatory mediator S100a8 levels
Evaluation of retinal protection in ischemia-reperfusion model
Sfrp2 effectively inhibited S100a8 levels, reducing neuroinflammation.
TRAF6-TAK1-NF-κB signaling pathway was blocked by Sfrp2 action.
Protection of neural tissue was observed following ischemia-reperfusion.

Abstract

Sfrp2 in microglia inhibits TRAF6-TAK1-NF-κB signaling pathway and downstream inflammatory mediator S100a8 thereby attenuating neuroinflammation and protecting the retina in I/R. Sfrp2 may represent a protective strategy for neuronal degeneration in ischemic retinopathy.

Sfrp2 in Microglia Inhibited S100a8-Mediated Neuroinflammation and Protected Neural Damage Following Retinal Ischemia-Reperfusion

Key Points

Abstract

Cite This Study